Showing results (531-540 of 641) with videos related to

Sort By:
Pageof 65
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 10, 2026
Liver Transplantation in Japan: Registry by the Japanese Liver Transplantation SocietyKoji Umeshita, Susumu Eguchi, Takumi Fukumoto, et al.
Pathology International|April 5, 2021
KIFC1 regulates ZWINT to promote tumor progression and spheroid formation in colorectal cancerShintaro Akabane, Naohide Oue, Yohei Sekino, et al.
Transplantation Proceedings|February 8, 2024
Anti-Donor T-Cell Responses Are Not Necessarily Attenuated During Cytomegalovirus Infection in Kidney Transplant RecipientsKentaro Ide, Asuka Tanaka, Yuka Tanaka, et al.
The Journal of Surgical Research|February 2, 2024
Weekday Surgery Associated With Short-Term Outcomes in Patients With Colorectal CancersKouki Imaoka, Manabu Shimomura, Minoru Hattori, et al.
The American Surgeon|August 30, 2021
Risk Factors for Hepatocellular Carcinoma After Splenectomy in Liver Cirrhotic PatientsNaruhiko Honmyo, Tsuyoshi Kobayashi, Shintaro Kuroda, et al.
Transplantation|December 17, 2008
Using recipient's middle hepatic vein for drainage of the right paramedian sector in right liver graftHirotaka Tashiro, Hideki Ohdan, Toshiyuki Itamoto, et al.
Molecular Therapy. Methods & Clinical Development|April 5, 2021
Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapyHiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 9, 2024
Predictors of tolerability for postoperative adjuvant S1 plus docetaxel chemotherapy for gastric cancer: a multicenter retrospective studyKazuhiro Toyota, Kazuaki Tanabe, Mikihiro Kano, et al.
Surgery Today|January 18, 2013
Reliability and validity of a new living liver donor quality of life scaleYuki Morooka, Koji Umeshita, Akinobu Taketomi, et al.
Springerplus|November 3, 2016
A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II studyManabu Shimomura, Katsunori Shinozaki, Takao Hinoi, et al.
Pageof 65